Co-Diagnostics Advances Ebola Testing Innovation Globally
SALT LAKE CITY, July 28, 2026 Co-Diagnostics, Inc. has announced two significant milestones that strengthen global preparedness against Ebola...
Neurodegenerative Disease
Advertisement
Dasher Neuroscience Advances YA-101 Phase 2 Trial
TAIPEI, July 28, 2026 Dasher Neuroscience Holdings Inc. has successfully completed patient enrollment in its global Phase 2 clinical...
Galmed Advances Brain-Targeted Aramchol for Parkinson’s
Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...
ProMIS Neurosciences Reports Positive Phase 1b PMN310 Interim Data
CAMBRIDGE, Mass., July 28, 2026 ProMIS Neurosciences Inc. announced positive blinded six-month interim safety and biomarker data from the...
Zevra Therapeutics to Seek EU Re-Examination for Arimoclomol After CHMP Opinion
BOSTON – July 24, 2026 Zevra Therapeutics, Inc. has announced that the European Medicines Agency’s (EMA) Committee for Medicinal...
Advertisements
Minoryx Therapeutics Secures CHMP Backing for NEZGLYAL® in cALD
Barcelona, Spain and Düsseldorf, Germany – July 24, 2026 Minoryx Therapeutics and Neuraxpharm Group have received a positive opinion...
Sinopia Reports Positive Preclinical Parkinson’s Findings
SAN DIEGO, July 15, 2026 Sinopia Biosciences announced the publication of preclinical research in Science Translational Medicine supporting SB-0110,...
Spinogenix Reports Durable Tazbentetol Alzheimer’s Data
LOS ANGELES, Calif., July 14, 2026 Spinogenix, Inc. has announced encouraging long-term clinical data demonstrating that its investigational therapy...
ProMIS Reports First Human PMN310 Evidence
CAMBRIDGE, Mass., July 14, 2026 ProMIS Neurosciences presented the first human evidence that its investigational Alzheimer’s disease therapy PMN310...
CervoMed Reports Positive Clinical, Biomarker and MRI Data for Neflamapimod at AAIC 2026
BOSTON, July 14, 2026 CervoMed presented new clinical, plasma biomarker, pharmacokinetic, and imaging analyses at the Alzheimer’s Association International...
Advertisement
